Literature DB >> 9598902

Aspects of use of antimalarials in systemic lupus erythematosus.

D D Gladman1, M B Urowitz, J L Senécal, P J Fortin, R E Petty, J M Esdaile, S Carrette, S M Edworthy, C D Smith, J C Thorne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9598902

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.

Authors:  J-X Wang; W Tang; L-P Shi; J Wan; R Zhou; J Ni; Y-F Fu; Y-F Yang; Y Li; J-P Zuo
Journal:  Br J Pharmacol       Date:  2007-01-29       Impact factor: 8.739

2.  Polymorphism of the beta3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine.

Authors:  J F Muñoz-Valle; M Vázquez-Del Mercado; S Ruiz-Quezada; E Oregón-Romero; R E Navarro-Hernández; J Ramírez-Barragán; G Martínez-Bonilla; G Bernard-Medina; B E Bastidas-Ramírez; B Ruiz-Madrigal; A Panduro
Journal:  Rheumatol Int       Date:  2003-03-12       Impact factor: 2.631

Review 3.  Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection.

Authors:  Jasvinder Singh Bhatti; Gurjit Kaur Bhatti; Naina Khullar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2020-08-18       Impact factor: 5.590
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.